The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Oct. 24, 2018
Applicant:

Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd., Shanghai, CN;

Inventors:

Wenzhi Tian, Shanghai, CN;

Song Li, Shanghai, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/70 (2006.01); C12N 15/81 (2006.01); A61K 38/17 (2006.01); A61P 37/00 (2006.01); A61P 1/00 (2006.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1774 (2013.01); A61P 1/00 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07K 14/70596 (2013.01); C12N 15/70 (2013.01); C12N 15/81 (2013.01);
Abstract

The present invention provides a recombinant fusion protein containing an anti-PD-L1 antibody, with at least one paratope of the anti-PD-L1 antibody linked via a linker to an extracellular Ig-like domain of a signal-regulator protein (SIRP) at N-terminus of a heavy chain or a light chain, wherein the recombinant fusion protein can bind to CD47, PD-L1 and FcR simultaneously. The present invention also provides a polynucleotide encoding the recombinant fusion protein, an expression vector containing the polynucleotide, a method for producing the recombinant protein and a method for treating a disease caused by over expression of CD47 and/or PD-L1 using the recombinant protein.


Find Patent Forward Citations

Loading…